HOUSTON, TX – On April 23, 2020 President Donald J. Trump and Bill Bryan of the DHS Science and Technology Directorate highlighted UV Light’s ability to kill COVID-19 in rapid fashion. President Trump also inquired about the possibility of using UV Light within a patient’s body to treat COVID-19.
ROCOMP GLOBAL, LLC, Houston, Texas and Tampa Bay, Florida, owns several U.S. and international patents for conveying UV Light into various parts of a patient’s body using hypodermic needles including small gauge needles and nanoneedles, which makes the process simple and even usable in pediatrics.
ROCOMP GLOBAL’s system includes a programmable light source that can allow radiant energy to extend across part of the electromagnetic spectrum enabling projection of radiant energy and IV fluid through needles to localized sites of the body. ROCOMP GLOBAL’s patented technology may be used to target bloodborne pathogens, promote tissue healing, as well as for stem cell photo-activation and proliferation. Examples of localized sites to direct radiant energy include veins, organs, tissue, bone, the spinal canal, body cavities and specific regions of the brain. In addition, the IV fluid may vary for particular treatment protocols.
ROCOMP GLOBAL has also patented a portable device with a built-in power source and light source for use in remote locations by emergency personnel, the military, and medical volunteers.
As the world continues to tackle COVID-19 and with the rise of antibiotic resistant bacteria, ROCOMP GLOBAL provides a much needed solution for the delivery of radiant energy into the body.
About ROCOMP GLOBAL
ROCOMP GLOBAL, LLC, is a Texas based company with a main office in Houston, Texas, and an R&D office located in Clearwater, Florida. To contact ROCOMP GLOBAL regarding venture opportunities or for more information, send inquiries to info@rocompglobal.com.